1
Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Condition(s):Hematopoietic/Lymphoid Cancer; Acute Myeloid LeukemiaLast Updated:November 4, 2019Terminated